Oncogenic viruses rewire the epigenome in human cancer
Frontiers in Cellular and Infection Microbiology · 10.06.2025 · 15
DOI: 10.3389/fcimb.2025.1617198 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 10.06.2025. Verfasst von Jhommara Bautista und 1 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador. Hauptthemen laut MEDLINE: Neoplasms, Oncogenic Viruses, Epigenome, Epigenesis, Genetic. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Viruses contribute to approximately 15–20% of global cancer cases, yet the full spectrum of their oncogenic mechanisms continues to be uncovered. Beyond the classical roles of genome integration, chronic inflammation, and immune evasion, mounting evidence reveals that oncogenic viruses—including the human papillomavirus (HPV), Epstein–Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), and Human T-cell leukemia virus type 1 (HTLV-1)—profoundly reshape the host epigenome to establish persistent infection and promote tumorigenesis. These viruses orchestrate widespread and durable changes in DNA methylation, histone modification, chromatin accessibility, and non-coding RNA expression, silencing tumor suppressors, deregulating oncogenic pathways, and inducing stemness-like phenotypes. In this review, we provide a comprehensive synthesis of how distinct oncogenic viruses modulate the epigenetic landscape across tissue contexts, with a focus on cervical, hepatic, and lymphoepithelial cancers. We also explore how these virus-induced epigenetic “scars” may persist after viral clearance and highlight recent advances in therapeutic targeting. Emerging therapeutic strategies that integrate oncolytic virotherapy, epigenetic drugs, and immune modulation through combinational therapy offer synergistic mechanisms to overcome immune resistance and epigenetic silencing in virus-induced cancers. These integrated approaches hold transformative potential for more durable and targeted treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.
- Facultade de Ciencias, Campus de A Zapateira, Universidade da Coruña, A Coruña, Spain.
- Instituto de Investigación Biomédica de A Coruña (INIBIC), Universidade da Coruña, A Coruña, Spain.
Zitieren
APA
Bautista, J., & Lopez-Cortes, A. (2025). Oncogenic viruses rewire the epigenome in human cancer. Frontiers in Cellular and Infection Microbiology, 15. https://doi.org/10.3389/fcimb.2025.1617198
Vancouver
Bautista J, Lopez-Cortes A. Oncogenic viruses rewire the epigenome in human cancer. Frontiers in Cellular and Infection Microbiology. 2025;15. doi:10.3389/fcimb.2025.1617198
BibTeX
@article{Bautista2025,
author = {Bautista, Jhommara and Lopez-Cortes, Andrés},
title = {Oncogenic viruses rewire the epigenome in human cancer},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
volume = {15},
doi = {10.3389/fcimb.2025.1617198}
}
EUVIMED